Transcriptional Control of Mitochondrial Bioenergetic Function
线粒体生物能功能的转录控制
基本信息
- 批准号:8502055
- 负责人:
- 金额:$ 38.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-08-15 至 2017-03-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAdipocytesAdipose tissueAdrenergic AgentsAffectAmino AcidsAnimalsApplications GrantsAtherosclerosisAutomobile DrivingBiochemicalBiochemical ProcessBioenergeticsBody WeightBrown FatCellsComplexCultured CellsCyclic AMPDefectDiabetes MellitusDietDiseaseEnergy IntakeEnergy MetabolismEquilibriumFamilyFatty acid glycerol estersGene ExpressionGenesGeneticGenetic TranscriptionGoalsHeatingHomeostasisInvestigationLaboratoriesMaintenanceMediatingMetabolicMetabolic DiseasesMitochondriaMitochondrial ProteinsMolecularMolecular AnalysisMusMuscle CellsMuscle FibersNon-Insulin-Dependent Diabetes MellitusNuclearNuclear Hormone ReceptorsNutrientObesityOutcome StudyPathway interactionsPhosphorylationPolycombPreparationProcessProteinsRecruitment ActivityRegulationRepressor ProteinsRespirationSignal PathwaySignal TransductionSiteSkeletal MuscleSystemTestingTissuesTranscription CoactivatorTranscriptional RegulationTranslatingWorkYY1 Transcription Factoradrenergicbasechromatin proteinenergy balancefeedinggain of functionglucose metabolismin vivolipid metabolismloss of functionmetabolomicsmouse modelnuclear respiratory factoroxidationprotein complexprotein expressionpublic health relevanceresearch studyscaffoldskeletal
项目摘要
DESCRIPTION (provided by applicant): Energy expenditure (a major component of body weight) is regulated through a complex regulatory network formed by signaling and transcriptional components that control bioenergetic/metabolic function. Skeletal muscle and beige/brown adipose are key tissues that account for a large fraction of energy expenditure. Adrenergic/cAMP signaling is one of the powerful pathways that affect energy balance and cellular bioenergetics. Defects in components of the signaling/transcriptional and mitochondrial bioenergetic system is sufficient to promote obesity and associated disorders such as type 2 diabetes and atherosclerosis. Importantly, maintenance and activation of mitochondrial bioenergetic function strictly depend on basal and regulated transcription of nuclear genes encoding for mitochondrial proteins. Among the transcriptional regulators of these mitochondrial processes are the PGC1 family of coactivators and transcription factors including Nuclear Respiratory Factors, Hormone Nuclear Receptors and YY1. In the last years, our laboratory has identified the transcription factor YY1 as a key regulator of nuclear mitochondrial genes that has a major impact in mitochondrial bioenergetic capacity, both in cultured cells and in animals. Depending on YY1 phosphorylation at specific sites, phospho-YY1 forms an active complex on mitochondrial genes through recruitment of PGC1¿. In contrast, dephospho-YY1 forms a repressor complex through interacting with Polycomb Proteins that suppresses the expression of mitochondrial genes. Importantly, one of the signals that govern YY1-dependent phosphorylation interaction is the cAMP pathway. Based on these findings, the major goal of this proposal is to identify the regulatory mechanisms driving mitochondrial gene expression through YY1 transcriptional complex and to assess the functionality using in-vivo mouse models of obesity and diabetes. We have three Specific Aims: Aim 1 proposes to perform molecular mechanistic analysis of how the YY1 transcriptional complex controls mitochondrial function. Aim 2 is devoted to carry out cellular and functional mitochondrial bioenergetic and metabolic analysis mediated by the YY1 transcriptional protein complex in skeletal and adipose cultured cells. Aim 3 is focused to perform in-vivo metabolic and energetic analysis mediated by the YY1 transcription factor in skeletal muscle and adipose tissues. We will use genetic mouse models with gain and loss-of-function of YY1 in these tissues. The outcomes of these studies will provide the identification of the molecular mechanisms by which the YY1 transcriptional complex regulates mitochondrial bioenergetic capacities and how defects in this complex result in dysregulated mitochondrial function and energy balance. Based on the fact that these pathways are altered in metabolic diseases such as obesity and diabetes, studies proposed in this grant application might translate into potential therapies.
描述(由适用提供):能量消耗(体重的主要组成部分)是通过控制生物能/代谢功能的信号传导和转录组件形成的复杂调节网络来调节的。骨骼肌和米色/棕色脂肪是关键组织,其占能量消耗的一部分。肾上腺素/cAMP信号传导是影响能量平衡和细胞生物能学的强大途径之一。信号/转录和线粒体生物能系统组成部分的缺陷足以促进肥胖和相关疾病,例如2型糖尿病和动脉粥样硬化。重要的是,线粒体生物能功能的维持和激活严格取决于编码线粒体蛋白的核基因的基本和调节转录。在这些线粒体过程的转录调节剂中,有共激活因子和转录因子的PGC1家族,包括核呼吸因子,激素核受体和YY1。在过去的几年中,我们的实验室将转录因子YY1确定为核线粒体基因的关键调节剂,在培养的细胞和动物中,对线粒体生物能力产生了重大影响。根据特定部位的YY1磷酸化,磷酸YY1通过募集PGC1募集在线粒体基因上形成活跃的复合物。相比之下,Dephospho-Yy1通过与抑制线粒体基因表达的多角膜蛋白相互作用而形成了复制复合物。重要的是,依赖YY1依赖的光磷酸化相互作用的信号之一是cAMP通路。基于这些发现,该提案的主要目标是通过YY1转录复合物确定驱动线粒体基因表达的调节机制,并使用肥胖和糖尿病的体内小鼠模型评估功能。我们有三个特定的目的:目标1提案,以对YY1转录复合物如何控制线粒体功能进行分子机械分析。 AIM 2致力于在骨骼和脂肪培养的细胞中介导的细胞和功能性线粒体生物能和代谢分析。 AIM 3专注于进行体内代谢和能量分析,该分析是由骨骼肌和脂肪组织中的YY1转录因子介导的。我们将使用这些组织中具有YY1功能的遗传小鼠模型。这些研究的结果将提供分子机制的鉴定,YY1转录复合物调节线粒体生物能力的能力以及该复合物中的缺陷如何导致线粒体功能和能量平衡失调。基于这些途径在肥胖症和糖尿病等代谢疾病中改变的事实,该赠款应用中提出的研究可能会转化为潜在的疗法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Pere Puigserver其他文献
Pere Puigserver的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Pere Puigserver', 18)}}的其他基金
Regulatory mechanisms of mitochondrial cristae biogenesis and thermogenic function
线粒体嵴生物发生和产热功能的调节机制
- 批准号:
10716595 - 财政年份:2023
- 资助金额:
$ 38.99万 - 项目类别:
Mitoribosome protein translation signaling and survival mechanisms
线粒体核糖体蛋白翻译信号传导和生存机制
- 批准号:
10714636 - 财政年份:2023
- 资助金额:
$ 38.99万 - 项目类别:
Mitochondrial Protein Translation Signaling and Survival Mechanisms
线粒体蛋白翻译信号和生存机制
- 批准号:
10462235 - 财政年份:2021
- 资助金额:
$ 38.99万 - 项目类别:
Metabolic and Bioenergetic Control in Mitochondrial Diseases
线粒体疾病的代谢和生物能控制
- 批准号:
9926273 - 财政年份:2017
- 资助金额:
$ 38.99万 - 项目类别:
Metabolic and epigenetic dependencies in melanomas during metastasis and targeted-drug resistance
黑色素瘤转移和靶向药物耐药过程中的代谢和表观遗传依赖性
- 批准号:
10599853 - 财政年份:2014
- 资助金额:
$ 38.99万 - 项目类别:
Metabolic and epigenetic dependencies in melanomas during metastasis and targeted-drug resistance
黑色素瘤转移和靶向药物耐药过程中的代谢和表观遗传依赖性
- 批准号:
10369725 - 财政年份:2014
- 资助金额:
$ 38.99万 - 项目类别:
Energy Expenditure and Metabolic Effects through Brown/Beige Adipose Clk2 Kinase
棕色/米色脂肪 Clk2 激酶的能量消耗和代谢效应
- 批准号:
9902407 - 财政年份:2011
- 资助金额:
$ 38.99万 - 项目类别:
Insulin Signaling and Metabolic Effects through CLK2 Kinase
CLK2 激酶的胰岛素信号传导和代谢效应
- 批准号:
8638955 - 财政年份:2011
- 资助金额:
$ 38.99万 - 项目类别:
Insulin Signaling and Metabolic Effects through CLK2 Kinase
CLK2 激酶的胰岛素信号传导和代谢效应
- 批准号:
8448785 - 财政年份:2011
- 资助金额:
$ 38.99万 - 项目类别:
相似国自然基金
CXCL1/CXCR2信号轴上调Bcl-2促进筋膜定植巨噬细胞迁移在皮下脂肪组织原位再生中的机制研究
- 批准号:82360615
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
脂肪干细胞外泌体miRNA-299a-3p调控巨噬细胞Thbs1缓解脂肪组织衰老的机制研究
- 批准号:82301753
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Arid5b调控Treg细胞脂肪组织适应性发育和代谢调控功能及机制探究
- 批准号:82371752
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
巨噬细胞Lp-PLA2对脂肪组织重塑的调控及其作用机制
- 批准号:32300977
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
巨噬细胞介导脂肪组织重构在塑化剂干扰系统能量代谢中的作用研究
- 批准号:82373625
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Adipokines, Sex Hormones and Cardiac Dysfunction in Postmenopausal Women of the MESA Study – An analysis of Secondary Data
MESA 研究中绝经后妇女的脂肪因子、性激素和心脏功能障碍 — 二手数据分析
- 批准号:
10507719 - 财政年份:2022
- 资助金额:
$ 38.99万 - 项目类别:
Predictors of Recidivism to Obesity in Weight-Reduced Individuals
体重减轻者肥胖累犯的预测因素
- 批准号:
10571766 - 财政年份:2021
- 资助金额:
$ 38.99万 - 项目类别:
Predictors of Recidivism to Obesity in Weight-Reduced Individuals
体重减轻者肥胖累犯的预测因素
- 批准号:
10190515 - 财政年份:2021
- 资助金额:
$ 38.99万 - 项目类别:
Integrative analysis of bulk and single-cell RNA-seq data for cardiometabolic disease
心脏代谢疾病的批量和单细胞 RNA-seq 数据的综合分析
- 批准号:
10448317 - 财政年份:2021
- 资助金额:
$ 38.99万 - 项目类别:
Predictors of Recidivism to Obesity in Weight-Reduced Individuals
体重减轻者肥胖累犯的预测因素
- 批准号:
10652665 - 财政年份:2021
- 资助金额:
$ 38.99万 - 项目类别: